Christine E. Seidman
CIK: 0001805745
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Merck & Co., Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 30, 2026MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
56 shares at avg. $145.31- - Jun 30, 2026MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
63 shares at avg. $128.50- - May 29, 2026MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
1.9K shares at avg. $118.72- - Mar 31, 2026MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
68 shares at avg. $120.29- - Dec 31, 2025MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
77 shares at avg. $105.26- - Sep 30, 2025MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
97 shares at avg. $83.93- - Jun 30, 2025MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
103 shares at avg. $79.16- - May 30, 2025MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
2.9K shares at avg. $76.84- - Mar 31, 2025MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
91 shares at avg. $89.76- - Dec 31, 2024MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
82 shares at avg. $99.48- - Sep 30, 2024MRK
Merck & Co., Inc.
Award(A)DirectPhantom Stock
72 shares at avg. $113.56-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 56 | $145.31 | - | Direct |
| Jun 30, 2026 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 63 | $128.50 | - | Direct |
| May 29, 2026 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 1,853 | $118.72 | - | Direct |
| Mar 31, 2026 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 68 | $120.29 | - | Direct |
| Dec 31, 2025 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 77 | $105.26 | - | Direct |
| Sep 30, 2025 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 97 | $83.93 | - | Direct |
| Jun 30, 2025 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 103 | $79.16 | - | Direct |
| May 30, 2025 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 2,863 | $76.84 | - | Direct |
| Mar 31, 2025 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 91 | $89.76 | - | Direct |
| Dec 31, 2024 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 82 | $99.48 | - | Direct |
| Sep 30, 2024 | MRK Merck & Co., Inc. | Award(A) Phantom Stock | 72 | $113.56 | - | Direct |
1-11 of 11 transactions
About Seidman Christine E
Seidman Christine E (SEC CIK 0001805745) files insider reports with the SEC as Director of Merck & Co., Inc. (MRK).
Signal8 holds 11 ownership filings by Seidman Christine E, all Form 4s, filed between Oct 1, 2024 and Oct 1, 2026. Those filings report 11 transactions, from Sep 30, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Seidman Christine E's filings is in RAHWAY, NJ.
Recent filings by Seidman Christine E
- Sep 30, 2026: Grant or award of MRK derivative securities (Form 4, code A).
- Jun 30, 2026: Grant or award of MRK derivative securities (Form 4, code A).
- May 29, 2026: Grant or award of MRK derivative securities (Form 4, code A).
- Mar 31, 2026: Grant or award of MRK derivative securities (Form 4, code A).
- Dec 31, 2025: Grant or award of MRK derivative securities (Form 4, code A).
Other insiders filing for Merck & Co., Inc. (MRK)
- DIAZ PAUL J, Director
- Maraldo David R., EVP & Pres. MMD
- Karsanbhai Surendralal Lanca, Director
- Coe Mary Ellen, Director
- Gupta Gaurav K, EVP, CIDO
- Guindo Chirfi, EVP, Access, Policy & Comms